secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2026-06-23T21:15:09+00:00
Accession:  0001193125-26-279776
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

FTC grants early termination of HSR waiting period for Catalyst-Angelini merger
-------------------------------------------------------------------------------

- FTC early termination of HSR Act waiting period granted June 16; Catalyst aware June 22.
- Closing still requires majority shareholder approval and other customary conditions.
- Parties expect deal to close in Q3 2026.
- Catalyst shareholders to vote on merger as detailed in definitive proxy statement filed June 8.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312526279776/0001193125-26-279776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312526279776/d166178d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-279776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer